Category:

International News

Latest

Aon forms EMEA M&A and Transaction Solutions Advisory Board to support growth and expansion of M&A practice

The new advisory board will support the growth and development of Aon’s M&A practice across the UK and EMEA, as it continues to expand its client offerings to include solutions for intellectual property, cyber security and digital performance, retirement, benefits, talent and compensation, structured credit, tax and litigation risks, ESG and more.

read more

WTO mulling intellectual property waivers for vaccines

The argument, part of a long-running debate about intellectual property protections, centers on lifting patents, copyrights, and protections for industrial design and confidential information to help expand the production and deployment of vaccines during supply shortages. The aim is to suspend the rules for several years, just long enough to beat down the pandemic.
The issue has become more pressing with a surge in cases in India, the world’s second-most populous country and a key producer of vaccines, including one for Covid-19 that relies on technology from Oxford University and British-Swedish pharmaceutical maker AstraZeneca.

read more

Debris from China space rocket likely to fall in international waters -Global Times

“All debris can be potential threats to spaceflight safety and the space domain,” the Pentagon said, adding that the 18th Space Control Squadron in California would be offering daily updates on the rocket body’s location from May 4. The White House said the United States was committed to addressing the risks of congestion due to space debris and wants to work with the international community “to promote leadership and responsible space behaviors.”

read more

Pfizer lifts sales forecast for coronavirus vaccine to $26 billion

The raised goal assumes 1.6 billion doses of vaccine, which is co-developed with BioNTech SE, will be delivered in the year, with the two-shot vaccine emerging as the best-selling product for the U.S. drugmaker in the first quarter.
“Based on what we’ve seen, we believe that a durable demand for our COVID-19 vaccine – similar to that of the flu vaccines – is a likely outcome,” Chief Executive Albert Bourla said in his prepared remarks.

read more